Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics
2023-08-25 15:14
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced
2023-08-25 10:06
Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy
2023-08-25 08:15
Antheia Achieves Major Commercial Milestone
2023-08-25 08:01
YS Biopharma Announces Purchase of Shares by Company Officers
2023-08-25 04:15
Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA
2023-08-24 20:00
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
2023-08-24 14:00
PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor
2023-08-24 09:51
Everest Medicines Announces Interim Results for First Half of 2023
2023-08-24 08:15
Samsung Biologics appoints new leadership to oversee quality and regulatory affairs
2023-08-24 07:59
Innovent Announces 2023 Interim Results and Business Updates
2023-08-23 19:38
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company
2023-08-23 17:40
USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023
2023-08-23 17:06
Maypharm Launches the world first Adipose Stem Cell Exosome hair filler, HAIRNA Exosome Hair Fill
2023-08-23 17:00
ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor
2023-08-23 10:51
Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis
2023-08-23 08:00
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
2023-08-22 22:00
Asieris Pharmaceuticals Unveils 2023 Semi-Annual Report, Demonstrating Initial Success of Specialty Pharma Strategy and Multi-Product Synergistic Commercialization
2023-08-22 20:58
Sanyou Biopharmaceuticals and Sinorda Biomedicine signed Strategic Cooperation Agreement for Advancing Innovative Drug Research and Development
2023-08-22 20:00
CARsgen Announced 2023 Interim Results
2023-08-22 19:30
1
46
47
48
49
50
375